In a study on MDSCs and prostate cancer, cancer patients had an increased proportion of M-MDSCs (defined in this study as cells with CD14+ characteristics, as the gating of MDSCs differs in each article) compared to controls [19,30,31]. This evidence concerns the gene CD14 and prostate carcinoma.